Showing 2,392 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Adherence

Study Explores Adherence Trajectories, Virologic Failure, and Interventions in U.S. Women With HIV

Editor's pick
The BodyPro
16 March 2023
Finance & funding

Study Bite: Late HIV Diagnosis Incurs High Healthcare Costs

Editor's pick
TheBodyPro
13 March 2023
PrEP

CROI 2023: Bone density profiles for long-acting cabotegravir vs TDF/FTC oral PrEP in young people

Editor's pick
i-Base
9 March 2023
Mental & emotional health problems

In HIV, Mental Health Impacts Viral Suppression, But Not Retention in Care

Editor's pick
Physician's Weekly
9 March 2023
Bad science & bogus treatments

No, Gammora HIV ‘cure kits’ not medically proven – stick to approved treatment

Editor's pick
Africa Check
1 March 2023
Treatment outcomes & life expectancy

Rates of Key Death Causes With HIV Falling in Europe/America

Editor's pick
NATAP
27 February 2023
Resistance

Treating HIV? Memorize These 12 HIV Resistance Mutations. Yes, Really.

Editor's pick
TheBodyPro
23 February 2023
New & experimental HIV treatments

Merck Opens Enrollment in New Phase 3 Clinical Trials with Investigational Once-Daily Islatravir in Combination with Doravirine for Treatment of HIV-1 Infection

Editor's pick
Merck press release
23 February 2023
Health problems in children & young people

Children's HIV Deaths in Africa Largely Preventable

Editor's pick
MedPage Today
23 February 2023
Injectable & long-acting HIV treatment

ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva (cabotegravir, rilpivirine) is as effective as daily oral Biktarvy (BIC/FTC/TAF) for the treatment of HIV-1

Editor's pick
ViiV press release
23 February 2023
Injectable & long-acting PrEP

Large Benefit With Long-Acting PrEP in Black People, but Some HIV Risk Persists

Editor's pick
MedPage Today
22 February 2023
Cardiovascular disease

HIV drug may be linked to increased risk of hypertension

Editor's pick
Medical Xpress
22 February 2023
HIV treatment for children & young people

ViiV Healthcare receives EU Marketing Authorisation for Triumeq PD

Editor's pick
ViiV press release
22 February 2023
Treatment outcomes & life expectancy

Trends in mortality in people living with HIV in an international cohort (RESPOND)

Editor's pick
NATAP
21 February 2023
Bad science & bogus treatments

‘Fraudulent and misleading’: why pricey herbal mix touted as a remedy for HIV falls flat

Editor's pick
Africa Check
9 February 2023
Contraception

New FSRH CEU guidance published: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception

Editor's pick
Faculty of Sexual and Reproductive Healthcare
7 February 2023
Menopause

Depression common in perimenopause, but HIV suppression rates remain steady, Swiss study reports

Editor's pick
The BodyPro
6 February 2023
Bad science & bogus treatments

COVID-19 vaccines don't contain HIV

Editor's pick
Associated Press
31 January 2023
Access to healthcare

Darunavir/ritonavir (DRV/r) Advocacy!

Editor's pick
AfroCAB
27 January 2023
Adherence

Does Cannabis Use Impair HIV Treatment Adherence?

Editor's pick
POZ
26 January 2023
Drug interactions & pharmacokinetics

Protease-to-Integrase Switch Greatly Reduces HIV Drug-Drug Interaction Risk

Editor's pick
TheBodyPro
25 January 2023
Injectable & long-acting HIV treatment

I Stopped Taking My HIV Pills

Editor's pick
POZ
20 January 2023
Injectable & long-acting HIV treatment

Study Bite: Despite Initial Interest, Many Don’t Switch to LA-ART

Editor's pick
TheBodyPro
20 January 2023
Side effects

Researchers identify how HIV/hepatitis drug harms the kidneys

Editor's pick
Medical Xpress
18 January 2023